Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Statins a potential therapeutic option in glaucoma

June 29, 2004

Istalol NDA for glaucoma approved

June 9, 2004

Tosufloxacin tosilate eye drops submitted for Japanese approval

June 9, 2004

SnET2 NDA accepted for priority review

June 4, 2004

Proposed financing at InSite to advance AzaSite development

June 4, 2004

Allergan and Kyorin sign Japanese agreement for Alphagan franchise

June 2, 2004

FDA sets date to discuss Macugen NDA

June 1, 2004

Allergan presents new prostaglandin analogues with utility as ocular hypotensive agents

May 28, 2004

NDA filing for Xibrom

May 27, 2004

Allergan and Senju sign Japanese licensing agreement for Lumigan

May 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...